Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anterior Horn Cell Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Riluzole
1.2.3 Edaravone
1.2.4 Glutamate Receptor Antagonist
1.2.5 Other
1.3 Market by Application
1.3.1 Global Anterior Horn Cell Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Amyotrophic Lateral Sclerosis
1.3.3 Spinal Muscular Atrophy
1.3.4 Multifocal Motor Neuropathy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anterior Horn Cell Disease Treatment Market Perspective (2018-2029)
2.2 Anterior Horn Cell Disease Treatment Growth Trends by Region
2.2.1 Global Anterior Horn Cell Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anterior Horn Cell Disease Treatment Historic Market Size by Region (2018-2024)
2.2.3 Anterior Horn Cell Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Anterior Horn Cell Disease Treatment Market Dynamics
2.3.1 Anterior Horn Cell Disease Treatment Industry Trends
2.3.2 Anterior Horn Cell Disease Treatment Market Drivers
2.3.3 Anterior Horn Cell Disease Treatment Market Challenges
2.3.4 Anterior Horn Cell Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anterior Horn Cell Disease Treatment Players by Revenue
3.1.1 Global Top Anterior Horn Cell Disease Treatment Players by Revenue (2018-2024)
3.1.2 Global Anterior Horn Cell Disease Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Anterior Horn Cell Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anterior Horn Cell Disease Treatment Revenue
3.4 Global Anterior Horn Cell Disease Treatment Market Concentration Ratio
3.4.1 Global Anterior Horn Cell Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anterior Horn Cell Disease Treatment Revenue in 2022
3.5 Anterior Horn Cell Disease Treatment Key Players Head office and Area Served
3.6 Key Players Anterior Horn Cell Disease Treatment Product Solution and Service
3.7 Date of Enter into Anterior Horn Cell Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anterior Horn Cell Disease Treatment Breakdown Data by Type
4.1 Global Anterior Horn Cell Disease Treatment Historic Market Size by Type (2018-2024)
4.2 Global Anterior Horn Cell Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Anterior Horn Cell Disease Treatment Breakdown Data by Application
5.1 Global Anterior Horn Cell Disease Treatment Historic Market Size by Application (2018-2024)
5.2 Global Anterior Horn Cell Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Anterior Horn Cell Disease Treatment Market Size (2018-2029)
6.2 North America Anterior Horn Cell Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024)
6.4 North America Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anterior Horn Cell Disease Treatment Market Size (2018-2029)
7.2 Europe Anterior Horn Cell Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024)
7.4 Europe Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anterior Horn Cell Disease Treatment Market Size (2018-2029)
8.2 Asia-Pacific Anterior Horn Cell Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Anterior Horn Cell Disease Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Anterior Horn Cell Disease Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anterior Horn Cell Disease Treatment Market Size (2018-2029)
9.2 Latin America Anterior Horn Cell Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024)
9.4 Latin America Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anterior Horn Cell Disease Treatment Market Size (2018-2029)
10.2 Middle East & Africa Anterior Horn Cell Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anterior Horn Cell Disease Treatment Introduction
11.1.4 Sanofi Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.1.5 Sanofi Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Anterior Horn Cell Disease Treatment Introduction
11.2.4 Novartis AG Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.2.5 Novartis AG Recent Development
11.3 Mitsubishi Chemical Group Corporation
11.3.1 Mitsubishi Chemical Group Corporation Company Detail
11.3.2 Mitsubishi Chemical Group Corporation Business Overview
11.3.3 Mitsubishi Chemical Group Corporation Anterior Horn Cell Disease Treatment Introduction
11.3.4 Mitsubishi Chemical Group Corporation Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.3.5 Mitsubishi Chemical Group Corporation Recent Development
11.4 BrainStorm Cell Limited
11.4.1 BrainStorm Cell Limited Company Detail
11.4.2 BrainStorm Cell Limited Business Overview
11.4.3 BrainStorm Cell Limited Anterior Horn Cell Disease Treatment Introduction
11.4.4 BrainStorm Cell Limited Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.4.5 BrainStorm Cell Limited Recent Development
11.5 Ionis Pharmaceuticals
11.5.1 Ionis Pharmaceuticals Company Detail
11.5.2 Ionis Pharmaceuticals Business Overview
11.5.3 Ionis Pharmaceuticals Anterior Horn Cell Disease Treatment Introduction
11.5.4 Ionis Pharmaceuticals Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.5.5 Ionis Pharmaceuticals Recent Development
11.6 Genervon Biopharmaceuticals, LLC
11.6.1 Genervon Biopharmaceuticals, LLC Company Detail
11.6.2 Genervon Biopharmaceuticals, LLC Business Overview
11.6.3 Genervon Biopharmaceuticals, LLC Anterior Horn Cell Disease Treatment Introduction
11.6.4 Genervon Biopharmaceuticals, LLC Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.6.5 Genervon Biopharmaceuticals, LLC Recent Development
11.7 Bausch Health Companies Inc
11.7.1 Bausch Health Companies Inc Company Detail
11.7.2 Bausch Health Companies Inc Business Overview
11.7.3 Bausch Health Companies Inc Anterior Horn Cell Disease Treatment Introduction
11.7.4 Bausch Health Companies Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.7.5 Bausch Health Companies Inc Recent Development
11.8 F. Hoffmann-La Roche Ltd
11.8.1 F. Hoffmann-La Roche Ltd Company Detail
11.8.2 F. Hoffmann-La Roche Ltd Business Overview
11.8.3 F. Hoffmann-La Roche Ltd Anterior Horn Cell Disease Treatment Introduction
11.8.4 F. Hoffmann-La Roche Ltd Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.8.5 F. Hoffmann-La Roche Ltd Recent Development
11.9 Treeway B.V
11.9.1 Treeway B.V Company Detail
11.9.2 Treeway B.V Business Overview
11.9.3 Treeway B.V Anterior Horn Cell Disease Treatment Introduction
11.9.4 Treeway B.V Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.9.5 Treeway B.V Recent Development
11.10 CYTOKINETICS
11.10.1 CYTOKINETICS Company Detail
11.10.2 CYTOKINETICS Business Overview
11.10.3 CYTOKINETICS Anterior Horn Cell Disease Treatment Introduction
11.10.4 CYTOKINETICS Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.10.5 CYTOKINETICS Recent Development
11.11 AB Science
11.11.1 AB Science Company Detail
11.11.2 AB Science Business Overview
11.11.3 AB Science Anterior Horn Cell Disease Treatment Introduction
11.11.4 AB Science Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.11.5 AB Science Recent Development
11.12 ADVANZ PHARMA
11.12.1 ADVANZ PHARMA Company Detail
11.12.2 ADVANZ PHARMA Business Overview
11.12.3 ADVANZ PHARMA Anterior Horn Cell Disease Treatment Introduction
11.12.4 ADVANZ PHARMA Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.12.5 ADVANZ PHARMA Recent Development
11.13 Biogen
11.13.1 Biogen Company Detail
11.13.2 Biogen Business Overview
11.13.3 Biogen Anterior Horn Cell Disease Treatment Introduction
11.13.4 Biogen Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.13.5 Biogen Recent Development
11.14 Orphazyme
11.14.1 Orphazyme Company Detail
11.14.2 Orphazyme Business Overview
11.14.3 Orphazyme Anterior Horn Cell Disease Treatment Introduction
11.14.4 Orphazyme Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.14.5 Orphazyme Recent Development
11.15 KRIGLE PHARMA, INC
11.15.1 KRIGLE PHARMA, INC Company Detail
11.15.2 KRIGLE PHARMA, INC Business Overview
11.15.3 KRIGLE PHARMA, INC Anterior Horn Cell Disease Treatment Introduction
11.15.4 KRIGLE PHARMA, INC Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.15.5 KRIGLE PHARMA, INC Recent Development
11.16 Aquestive Therapeutics, Inc
11.16.1 Aquestive Therapeutics, Inc Company Detail
11.16.2 Aquestive Therapeutics, Inc Business Overview
11.16.3 Aquestive Therapeutics, Inc Anterior Horn Cell Disease Treatment Introduction
11.16.4 Aquestive Therapeutics, Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.16.5 Aquestive Therapeutics, Inc Recent Development
11.17 Apotex Inc
11.17.1 Apotex Inc Company Detail
11.17.2 Apotex Inc Business Overview
11.17.3 Apotex Inc Anterior Horn Cell Disease Treatment Introduction
11.17.4 Apotex Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.17.5 Apotex Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anterior Horn Cell Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Riluzole
Table 3. Key Players of Edaravone
Table 4. Key Players of Glutamate Receptor Antagonist
Table 5. Key Players of Other
Table 6. Global Anterior Horn Cell Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Anterior Horn Cell Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Anterior Horn Cell Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Anterior Horn Cell Disease Treatment Market Share by Region (2018-2024)
Table 10. Global Anterior Horn Cell Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Anterior Horn Cell Disease Treatment Market Share by Region (2024-2029)
Table 12. Anterior Horn Cell Disease Treatment Market Trends
Table 13. Anterior Horn Cell Disease Treatment Market Drivers
Table 14. Anterior Horn Cell Disease Treatment Market Challenges
Table 15. Anterior Horn Cell Disease Treatment Market Restraints
Table 16. Global Anterior Horn Cell Disease Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Anterior Horn Cell Disease Treatment Market Share by Players (2018-2024)
Table 18. Global Top Anterior Horn Cell Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anterior Horn Cell Disease Treatment as of 2022)
Table 19. Ranking of Global Top Anterior Horn Cell Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Anterior Horn Cell Disease Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anterior Horn Cell Disease Treatment Product Solution and Service
Table 23. Date of Enter into Anterior Horn Cell Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Anterior Horn Cell Disease Treatment Revenue Market Share by Type (2018-2024)
Table 27. Global Anterior Horn Cell Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Anterior Horn Cell Disease Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Anterior Horn Cell Disease Treatment Revenue Market Share by Application (2018-2024)
Table 31. Global Anterior Horn Cell Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Anterior Horn Cell Disease Treatment Revenue Market Share by Application (2024-2029)
Table 33. North America Anterior Horn Cell Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Anterior Horn Cell Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Anterior Horn Cell Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Anterior Horn Cell Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Anterior Horn Cell Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Anterior Horn Cell Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 48. Sanofi Company Detail
Table 49. Sanofi Business Overview
Table 50. Sanofi Anterior Horn Cell Disease Treatment Product
Table 51. Sanofi Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 52. Sanofi Recent Development
Table 53. Novartis AG Company Detail
Table 54. Novartis AG Business Overview
Table 55. Novartis AG Anterior Horn Cell Disease Treatment Product
Table 56. Novartis AG Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 57. Novartis AG Recent Development
Table 58. Mitsubishi Chemical Group Corporation Company Detail
Table 59. Mitsubishi Chemical Group Corporation Business Overview
Table 60. Mitsubishi Chemical Group Corporation Anterior Horn Cell Disease Treatment Product
Table 61. Mitsubishi Chemical Group Corporation Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 62. Mitsubishi Chemical Group Corporation Recent Development
Table 63. BrainStorm Cell Limited Company Detail
Table 64. BrainStorm Cell Limited Business Overview
Table 65. BrainStorm Cell Limited Anterior Horn Cell Disease Treatment Product
Table 66. BrainStorm Cell Limited Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 67. BrainStorm Cell Limited Recent Development
Table 68. Ionis Pharmaceuticals Company Detail
Table 69. Ionis Pharmaceuticals Business Overview
Table 70. Ionis Pharmaceuticals Anterior Horn Cell Disease Treatment Product
Table 71. Ionis Pharmaceuticals Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 72. Ionis Pharmaceuticals Recent Development
Table 73. Genervon Biopharmaceuticals, LLC Company Detail
Table 74. Genervon Biopharmaceuticals, LLC Business Overview
Table 75. Genervon Biopharmaceuticals, LLC Anterior Horn Cell Disease Treatment Product
Table 76. Genervon Biopharmaceuticals, LLC Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 77. Genervon Biopharmaceuticals, LLC Recent Development
Table 78. Bausch Health Companies Inc Company Detail
Table 79. Bausch Health Companies Inc Business Overview
Table 80. Bausch Health Companies Inc Anterior Horn Cell Disease Treatment Product
Table 81. Bausch Health Companies Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 82. Bausch Health Companies Inc Recent Development
Table 83. F. Hoffmann-La Roche Ltd Company Detail
Table 84. F. Hoffmann-La Roche Ltd Business Overview
Table 85. F. Hoffmann-La Roche Ltd Anterior Horn Cell Disease Treatment Product
Table 86. F. Hoffmann-La Roche Ltd Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 87. F. Hoffmann-La Roche Ltd Recent Development
Table 88. Treeway B.V Company Detail
Table 89. Treeway B.V Business Overview
Table 90. Treeway B.V Anterior Horn Cell Disease Treatment Product
Table 91. Treeway B.V Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 92. Treeway B.V Recent Development
Table 93. CYTOKINETICS Company Detail
Table 94. CYTOKINETICS Business Overview
Table 95. CYTOKINETICS Anterior Horn Cell Disease Treatment Product
Table 96. CYTOKINETICS Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 97. CYTOKINETICS Recent Development
Table 98. AB Science Company Detail
Table 99. AB Science Business Overview
Table 100. AB Science Anterior Horn Cell Disease Treatment Product
Table 101. AB Science Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 102. AB Science Recent Development
Table 103. ADVANZ PHARMA Company Detail
Table 104. ADVANZ PHARMA Business Overview
Table 105. ADVANZ PHARMA Anterior Horn Cell Disease Treatment Product
Table 106. ADVANZ PHARMA Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 107. ADVANZ PHARMA Recent Development
Table 108. Biogen Company Detail
Table 109. Biogen Business Overview
Table 110. Biogen Anterior Horn Cell Disease Treatment Product
Table 111. Biogen Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 112. Biogen Recent Development
Table 113. Orphazyme Company Detail
Table 114. Orphazyme Business Overview
Table 115. Orphazyme Anterior Horn Cell Disease Treatment Product
Table 116. Orphazyme Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 117. Orphazyme Recent Development
Table 118. KRIGLE PHARMA, INC Company Detail
Table 119. KRIGLE PHARMA, INC Business Overview
Table 120. KRIGLE PHARMA, INC Anterior Horn Cell Disease Treatment Product
Table 121. KRIGLE PHARMA, INC Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 122. KRIGLE PHARMA, INC Recent Development
Table 123. Aquestive Therapeutics, Inc Company Detail
Table 124. Aquestive Therapeutics, Inc Business Overview
Table 125. Aquestive Therapeutics, Inc Anterior Horn Cell Disease Treatment Product
Table 126. Aquestive Therapeutics, Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 127. Aquestive Therapeutics, Inc Recent Development
Table 128. Apotex Inc Company Detail
Table 129. Apotex Inc Business Overview
Table 130. Apotex Inc Anterior Horn Cell Disease Treatment Product
Table 131. Apotex Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 132. Apotex Inc Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anterior Horn Cell Disease Treatment Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Anterior Horn Cell Disease Treatment Market Share by Type: 2022 VS 2029
Figure 3. Riluzole Features
Figure 4. Edaravone Features
Figure 5. Glutamate Receptor Antagonist Features
Figure 6. Other Features
Figure 7. Global Anterior Horn Cell Disease Treatment Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 8. Global Anterior Horn Cell Disease Treatment Market Share by Application: 2022 VS 2029
Figure 9. Amyotrophic Lateral Sclerosis Case Studies
Figure 10. Spinal Muscular Atrophy Case Studies
Figure 11. Multifocal Motor Neuropathy Case Studies
Figure 12. Other Case Studies
Figure 13. Anterior Horn Cell Disease Treatment Report Years Considered
Figure 14. Global Anterior Horn Cell Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Anterior Horn Cell Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Anterior Horn Cell Disease Treatment Market Share by Region: 2022 VS 2029
Figure 17. Global Anterior Horn Cell Disease Treatment Market Share by Players in 2022
Figure 18. Global Top Anterior Horn Cell Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anterior Horn Cell Disease Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Anterior Horn Cell Disease Treatment Revenue in 2022
Figure 20. North America Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Anterior Horn Cell Disease Treatment Market Share by Country (2018-2029)
Figure 22. United States Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Anterior Horn Cell Disease Treatment Market Share by Country (2018-2029)
Figure 26. Germany Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Anterior Horn Cell Disease Treatment Market Share by Region (2018-2029)
Figure 34. China Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Anterior Horn Cell Disease Treatment Market Share by Country (2018-2029)
Figure 42. Mexico Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Anterior Horn Cell Disease Treatment Market Share by Country (2018-2029)
Figure 46. Turkey Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Sanofi Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 49. Novartis AG Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 50. Mitsubishi Chemical Group Corporation Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 51. BrainStorm Cell Limited Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 52. Ionis Pharmaceuticals Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 53. Genervon Biopharmaceuticals, LLC Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 54. Bausch Health Companies Inc Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 55. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 56. Treeway B.V Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 57. CYTOKINETICS Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 58. AB Science Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 59. ADVANZ PHARMA Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 60. Biogen Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 61. Orphazyme Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 62. KRIGLE PHARMA, INC Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 63. Aquestive Therapeutics, Inc Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 64. Apotex Inc Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed